Patients' views on the quality of health care for rheumatoid arthritis

Rheumatology
H LemppGabrielle Kingsley

Abstract

To study the experiences and views of patients with rheumatoid arthritis (RA) on the quality of health care received in primary and secondary care. Semi-structured interviews with 26 individual patients with RA; these were stratified by sex, ethnicity and disease duration, based on the treated prevalence cohort of patients attending two outpatient clinics in South East England. Patients highlighted four main factors which influenced their attitude and approach towards hospital staff and the treatment offered: (i) their past experiences with the National Health Service (NHS), (ii) their own health beliefs, (iii) professional attitudes (e.g. listening to patients, receiving feedback on disease processes) and (iv) organizational aspects (e.g. good communication between health professionals) which would make their visits to the outpatient clinic easier. Most patients no longer see themselves as passive recipients of care. They appreciate acknowledgement from health care professionals of their contribution towards management of their own chronic illness, and welcome a more equal dialogue with health care staff. This is consistent with the emphasis of the Department of Health document on 'Supporting People with Long-term Conditions' ...Continue Reading

References

Feb 1, 1975·Social Science & Medicine·C L Wiener
Jun 1, 1990·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·C K RossE Budiman-Mak
Feb 1, 1988·Western Journal of Nursing Research·D L Sexton, B H Munro
Nov 1, 1995·Nursing Standard·S Ryan
Feb 1, 1997·Journal of Advanced Nursing·J Hill
Feb 25, 2000·BMJ : British Medical Journal·E H Wagner
Oct 27, 2001·Journal of Clinical Pharmacy and Therapeutics·E VermeireJ Denekens
Jan 31, 2002·Health Affairs·E H WagnerA Bonomi
Aug 21, 2002·JAMA : the Journal of the American Medical Association·Kevin Grumbach, Thomas Bodenheimer
Jan 24, 2004·BMJ : British Medical Journal·Richard Lewis, Jennifer Dixon
Feb 11, 2004·Current Opinion in Rheumatology·Thea P M Vliet Vlieland
Nov 18, 2004·BMJ : British Medical Journal·Sarah HewlettMark G Perry
Dec 14, 2004·Best Practice & Research. Clinical Rheumatology·David L ScottGabrielle Kingsley
Mar 19, 2005·BMJ : British Medical Journal·Trish Groves, Edward H Wagner
Mar 19, 2005·BMJ : British Medical Journal·Colin Campbell, Gill McGauley

❮ Previous
Next ❯

Citations

May 12, 2009·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Heidi LemppMichele Tansella
Oct 28, 2006·Annals of the Rheumatic Diseases·J S SmolenUNKNOWN Working Group on the Rituximab Consensus Statement
Nov 5, 2011·International Journal of Qualitative Studies on Health and Well-being·Ulrika BergstenBarbro Arvidsson
Oct 1, 2006·Expert Review of Pharmacoeconomics & Outcomes Research·David L Scott, Heidi Lempp
Sep 18, 2007·Best Practice & Research. Clinical Rheumatology·Heidi Lempp, Gabrielle Kingsley
May 20, 2009·Musculoskeletal Care·Ulrika BergstenUNKNOWN EIRA Study Group
Feb 11, 2014·Journal of the American Association of Nurse Practitioners·Elizabeth SaltSusan K Frazier
Apr 19, 2016·International Journal of Clinical Rheumatology·María F Marengo, María E Suarez-Almazor
Jan 23, 2015·International nursing review·L W PohW-C S Chan
Mar 17, 2017·The Medical Journal of Australia·Louisa ChouAnita E Wluka
Dec 14, 2019·Current Rheumatology Reviews·Rostislav A GrekhovLiudmila N Shilova

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.